Financing channel feed

For­mer col­lege room­mates com­bine health and tech back­grounds to raise $58M for new fund

Last year
Health Tech

Obe­si­ty and di­a­betes biotech Car­mot Ther­a­peu­tics files for IPO

Last year
Startups

Biotech’s IPO out­look for the rest of the year sours in wake of war, broad­er in­dus­try strug­gles

Last year
Startups

Scoop: Rakuten Med­ical tar­gets year-end close for $100M+ Se­ries E to fund pho­toim­munother­a­py pipeline: #Jef­feries23

Last year
R&D

Scoop: Cell­Prothera eyes $30M round for PhI­II tri­al of cell ther­a­py for heart at­tacks: #Jef­feries23

Last year
Cell/Gene Tx

NMD Phar­ma se­cures €75M from in­sid­ers for three PhII tri­als in neu­ro­mus­cu­lar dis­or­ders

Last year
Startups

Scoop: Smart Im­mune tar­gets $54M Se­ries A to ad­vance T cell prog­en­i­tor ther­a­py: #Jef­feries23

Last year
Cell/Gene Tx

Mur­al On­col­o­gy spins out from Alk­er­mes with $275M and a lead im­munother­a­py pro­gram

Last year
Startups

Ex­clu­sive: NTx rais­es $47.5M Se­ries B to com­mer­cial­ize pro­tein, mR­NA man­u­fac­tur­ing plat­forms 

Last year
Manufacturing

Sanofi-backed T-Ther­a­peu­tics bags $59M in Se­ries A to un­lock po­ten­tial of TCR ther­a­peu­tics: #Jef­feries23

Last year
Startups

Eye­Bio dou­bles the size of its Se­ries A as an­ti-VEGF vet­er­ans seek new ways of treat­ing reti­nal dis­eases

Last year
Startups

MBrace Ther­a­peu­tics cap­i­tal­izes on ADC wave with $85M Se­ries B to en­ter the clin­ic this quar­ter

Last year
Startups

Swiss can­cer vac­cine biotech Nous­com rais­es $72M Se­ries C for PhII tri­als

Last year
Startups

Neu­rode­gen­er­a­tive dis­ease-fo­cused Vec­to­rY nabs $138M to bring ALS vec­tor­ized an­ti­body to clin­ic

Last year
Startups

UCB, Eli Lil­ly-backed Via­Nautis rais­es $25M in Se­ries A to de­vel­op ge­net­ic nanomed­i­cines

Last year
Startups

CAR­GO's $281M IPO could be the last list­ing of 2023 af­ter mar­ket's 'dras­tic turn'

Last year
Startups
Cell/Gene Tx

For­ward Ther­a­peu­tics, the first biotech from Curie.Bio, rais­es $50M for oral small mol­e­cules in im­munol­o­gy

Last year
Startups

Flag­ship Pi­o­neer­ing takes an­oth­er big step across the globe, plant­i­ng its biotech flag in Asia

Last year
Startups
Bioregnum

WuXi XDC eyes IPO to boost ADC, bio­con­ju­gate man­u­fac­tur­ing foot­print

Last year
Manufacturing

Lil­ly backs Or­so­Bio's $60M Se­ries A for PhII tri­als in obe­si­ty and NASH

Last year
Startups
Pharma

Ex­clu­sive: With back­ing of Ravens own­er, Black­bird launch­es with $100M to boost Bal­ti­more’s biotech scene

Last year
Startups

Dutch-US biotech rais­es $61M to test ex-Mit­subishi Tan­abe drug for schiz­o­phre­nia

Last year
Startups
Deals

CAR­GO Ther­a­peu­tics eyes one of 2023's largest IPOs in a dull year for list­ings

Last year
Startups
Cell/Gene Tx

Lex­eo Ther­a­peu­tics joins small class of 2023 biotech IPOs in $100M Nas­daq list­ing

Last year
Startups
Cell/Gene Tx
First page Previous page 23242526272829 Next page Last page
A service from the Financial Times